re7 biotech plans to use psilocybin as a groundbreaking medical compound to help curing pain related diseases. Based on our exclusively developed Psilobin® formulation re7 is working on new ways of revolutionizing pain therapies.
Psilocybin is a naturally occurring compound found in mushrooms of the genus Psilocybe. Synthesized psilocybin has been used in preclinical and clinical researches since 1959.
„With re7 biotech we want to provide proof of the healing power of psilocybin with clinical trials and enable patients to benefit from this treatment.“
Realising what psilocybin can possibly do for mental diseases like TRD and MDD, re7 biotech became aware that this natural compound could also be a potential remedy for pain related diseases.
This was the reason why we started researching, evaluating anecdotal evidence and realized the future potential of psilocybin. re7 is currently initiating two innovative medical trials with leading German University Hospitals to develop psilocybin based pain therapies for rare diseases.
As a biopharmaceutical company we want to develop new compounds like our exclusive Psilobin® formulation to unlock highly effective evidence based healing processes and and set new standards for the future of modern medicine.
% of the world's population affects chronic pain.
% of patients with chronic pain are affected by severe depression.
% of people committing suicide due to chronic pain between 2003-2014.
% of chronic pain patients receive an opioid prescription despite research showing it does NOT improve the quality of life for patients.